击穿百万价格后,首批转目录的创新药销量能大爆发吗?

第一财经
12 hours ago

“创新药要爆发了,这款CAR-T明年销量会大涨!”一位资深医药人士今天听到CAR-T细胞药物瑞基奥仑赛进入基本医保后难掩激动。   药明巨诺的瑞基奥仑赛注射液成为继诺西那生钠之后,又一款靠医保谈判“破圈”的明星高值药。这位人士直言,随着CAR-T药物动辄百万的“天价”壁垒被击穿,创新药正迎来打破支付天花板的全新想象空间。   今年医保目录调整首次建立了“双目录”衔接机制,允许商保目录品种申报基本...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10